FDA Adverse Event Injury Summary report: N

ADVANTA V12 COVERED STENT

MDR report key: 6814958 · Received August 23, 2017

Report

Report Number
3011175548-2017-00067
Event Type
Injury
Date Received
August 23, 2017
Report Date
August 16, 2017
Manufacturer
ATRIUM MEDICAL CORPROATION
Product Code
NIN
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A COMPLETE INVESTIGATION WAS NOT ABLE TO BE PERFORMED AS NO PRODUCT CODE, LOT NUMBER, OR SAMPLE WAS PROVIDED. QUESTIONS WERE SENT TO THE AUTHOR OF THE ARTICLE. NO RESPONSE WAS RECEIVED. THE STUDY CONCLUDED THAT C-EVAR IS FEASIBLE AND EFFICIENT TO TREAT JAA IN PATIENTS UNSUITABLE FOR FENESTRATED BRANCHED ENDOGRAFTS (FBE). HOWEVER, IN THIS PRELIMINARY EXPERIENCE, COMPLICATIONS OF DEVICES INSERTION AND TYPE I ENDOLEAKS WERE NOT RARE. ASSOCIATED FILES: 3011175548-2017-00062, 3011175548-2017-00063, 3011175548-2017-00064, 3011175548-2017-00065, 3011175548-2017-00066, 3011175548-2017-00068.

Description of Event or Problem · 1

RECEIVED AN ARTICLE TITLED: TECHNICAL ASPECTS, CURRENT INDICATIONS, AND RESULTS OF CHIMNEY GRAFTS FOR JUXTARENAL AORTIC ANEURYSMS PUBLISHED IN THE JOURNAL OF VASCULAR SURGERY. THE PURPOSE OF THIS ARTICLE WAS TO REPORT PRELIMINARY EXPERIENCE WITH CHIMNEY GRAFTS FOR JUXTARENAL AORTIC ANEURYSMS (JAA) IN AN EFFORT TO REVIEW ITS INDICATIONS IN THE ERA OF FENESTRATED BRANCHED ENDOGRAFTS. FROM 2000 TO 2010, 57 PATIENTS WITH ENDOVASCULAR REPAIR OF AORTIC ANEURYSMS WERE REVIEWED. SIXTEEN (16) PATIENTS WITH C-EVAR. PER THE ARTICLE, PROCEDURAL COMPLICATIONS INCLUDED ONE PATIENT WITH A RETROPERITONEAL HEMATOMA, RIGHT CVA, RIGHT RENAL INFARCTION RESULTING IN LEFT UPPER LIMB WEAKNESS AND STAGE III CHRONIC RENAL INSUFFICIENCY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
593895 ADVANTA V12 COVERED STENT PTFE COVERED STENT NIN ATRIUM MEDICAL CORPROATION

Patients

Seq Age Sex Outcome Treatment
1 78 YR Death